Search Within

Melanoma Disease Management Team

Formats
  1. Journal Article (1584)
  2. Meeting Abstract (783)
  3. Book Section (104)
  4. Review (68)
  5. Editorial (58)
  6. Research Letter (42)
  7. Guidelines (26)
  8. Conference Paper (22)
  9. Correspondence (21)
  10. Miscellaneous (16)
  11. Book Whole (11)
Groups
  1. Department of Medicine (1668)
  2. Survivorship Research (1183)
  3. Solid Tumor Oncology Division (1037)
  4. Department of Pathology and Laboratory Medicine (947)
  5. Surgery (939)
  6. Melanoma and Immunotherapeutics Service (783)

More Groups

People
  1. Klaus Busam (689)
  2. Daniel Coit (542)
  3. Allan Halpern (396)
  4. Michael Postow (362)
  5. Alexander Shoushtari (244)
  6. Jedd Wolchok (222)

More People

Years
  1. 2025 (56)
  2. 2024 (136)
  3. 2023 (160)
  4. 2022 (167)
  5. 2021 (149)
  6. 2020 (142)

More Years

Publications
  1. Journal of Clinical Oncology (264)
  2. Annals of Surgical Oncology (220)
  3. Journal of the American Academy of Dermatology (122)
  4. Journal of Investigative Dermatology (80)
  5. Modern Pathology (66)
  6. International Journal of Radiation Oncology, Biology, Physics (64)

More Publications

Publishers
  1. Springer (340)
  2. American Society of Clinical Oncology (279)
  3. Elsevier Inc. (227)
  4. Lippincott Williams & Wilkins (226)
  5. Wiley Blackwell (160)
  6. American Association for Cancer Research (157)

More Publishers

Results (2735)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathway alterations in stage II/III primary melanoma
    Journal Article

    Kostrzewa, C. E.; Luo, L.; Arora, A.; Seshan, V. E.; Ernstoff, M. S.; Edmiston, S. N.; Conway, K.; Gorlov, I.; Busam, K.; Orlow, I.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Clinical utility of melanoma sentinel lymph node biopsy nomograms
    Meeting Abstract

    Drebin, H. M.; Hosein, S.; Kurtansky, N.; Moy, A. P.; Ariyan, C. E.; Bello, D. M.; Brady, M. S.; Coit, D. G.; Marchetti, M. A.; Bartlett, E. K.
    Journal of the American College of Surgeons (2023)

    Fulltext@MSK | Save
  • Pencil beam scanning proton stereotactic body radiation therapy (SBRT): A robust single institution experience
    Meeting Abstract

    Lin, H.; Yu, F.; Gorovets, D.; Kabarriti, R.; Alektiar, K. M.; Ohri, N.; Hasan, S.; Tsai, P.; Shim, A.; Kang, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Favorable toxicity and local control with ultrahypofractionated radiation therapy (UH-RT) for melanoma of the lower genital tract (LGT)
    Meeting Abstract

    Silver, B.; White, C.; Zhang, Z.; Shoushtari, A.; Leitao, M. M.; Williams, V. M.; Alektiar, K. M.; Kollmeier, M. A.
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Quality of life before and after radiotherapy for early-stage keratinocyte carcinoma: A longitudinal analysis
    Meeting Abstract

    Barker, C. A.; Qin, N.; Ma, J.; Lee, E. H.
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • BRAF mutation status does not impact outcomes with tebentafusp in advanced cutaneous melanoma
    Meeting Abstract

    Shoushtari, A. N.; Middleton, M. R.; Hamid, O.; Meier, F.; Bauer, T.; Salama, A. K. S.; Kirkwood, J. M.; Ascierto, P. A.; Lorigan, P.; Mauch, C.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • A phase I dose escalation and expansion study of FHD-286, a novel BRG1/BRM (SMARCA4/SMARCA2) inhibitor, for the treatment of metastatic uveal melanoma
    Meeting Abstract

    Patel, S.; McKean, M.; Piperno-Neumann, S.; Shoushtari, A. N.; Hernandez-Aya, L.; Orloff, M.; Khan, S.; Montazeri, K.; Kapiteijn, E.; Buchbinder, E.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Effect of subsequent therapies including checkpoint inhibitors on overall survival in a phase III randomized trial of tebentafusp in first-line metastatic uveal melanoma: Long-term follow-up
    Meeting Abstract

    Orloff, M.; Watkins, C.; Carvajal, R. D.; Shoushtari, A. N.; Sacco, J. J.; Schlaak, M.; Gama, J.; Butler, M. O.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Comparison of intracranial (IC) response assessment criteria in patients (pts) with melanoma brain metastases (MBM) treated with combination nivolumab (NIVO) plus ipilimumab (IPI) in CheckMate 204
    Meeting Abstract

    Huang, R.; Youssef, G.; Nelson, T.; Wen, P.; Forsyth, P.; Hodi, F. S.; Margolin, K. A.; Algazi, A. P.; Hamid, O.; Lao, C. D.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Relapse free survival (RFS) at 3 years by pathological (path) response to neoadjuvant systemic treatment (NST) in patients (pts) with surgically resectable, high-risk melanoma
    Meeting Abstract

    Burton, E.; Milton, D.; Simpson, L.; Tetzlaff, M.; Glitza, I. C.; Ross, M. I.; Gershenwald, J. E.; McQuade, J.; Wong, M.; Patel, S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save